Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Henan Lingrui Pharmaceutical Co Ltd
Income from Continuing Operations
Henan Lingrui Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
|
Income from Continuing Operations
¥526.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Income from Continuing Operations
¥6.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income from Continuing Operations
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income from Continuing Operations
¥3.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income from Continuing Operations
¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income from Continuing Operations
¥4.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is Henan Lingrui Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
526.1m
CNY
Based on the financial report for Sep 30, 2023, Henan Lingrui Pharmaceutical Co Ltd's Income from Continuing Operations amounts to 526.1m CNY.
What is Henan Lingrui Pharmaceutical Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
18%
Over the last year, the Income from Continuing Operations growth was 19%. The average annual Income from Continuing Operations growth rates for Henan Lingrui Pharmaceutical Co Ltd have been 20% over the past three years , 16% over the past five years , and 18% over the past ten years .